BioStem Technologies, Inc.
BSEM
$4.02
$0.112.68%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.68M | 10.74M | 17.59M | 16.36M | 13.62M |
| Total Depreciation and Amortization | 283.00K | 230.90K | 230.10K | 203.90K | 258.50K |
| Total Amortization of Deferred Charges | 63.60K | 101.80K | 217.30K | 211.10K | 377.40K |
| Total Other Non-Cash Items | 5.78M | 5.35M | 4.32M | 5.64M | 7.48M |
| Change in Net Operating Assets | -3.70M | 2.49M | -2.52M | -6.10M | -6.84M |
| Cash from Operations | 7.11M | 18.91M | 19.84M | 16.32M | 14.91M |
| Capital Expenditure | -2.91M | -616.80K | -447.60K | -295.30K | -295.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -105.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.25M | -1.25M | -1.25M | -1.25M | -1.15M |
| Cash from Investing | -1.66M | -1.87M | -1.70M | -1.55M | -1.55M |
| Total Debt Issued | -- | -- | -- | -- | 60.90K |
| Total Debt Repaid | -1.17M | -1.13M | -461.70K | -747.90K | -1.20M |
| Issuance of Common Stock | 48.30K | 133.30K | 133.30K | 350.00K | 2.29M |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing | -1.12M | -993.00K | -328.40K | -397.90K | 1.14M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.33M | 16.05M | 17.81M | 14.37M | 14.50M |